Is DOTS-plus a feasible and cost-effective strategy?

by Paul Garner, Marissa Alejandria, Mary Ann Lansang
Published 2006-09-01

Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines.

by Manuel Alexander Haasis, Joyce Anne Ceria, Wantanee Kulpeng, Yot Teerawattananon, Marissa Alejandria
Published 2015-01-01

Prevalence and risk factors for trimethoprim–sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country

by Louie Mar Gangcuangco, Marissa Alejandria, Karl Evans Henson, Liezel Alfaraz, Rona Marie Ata, Maritess Lopez, Mediadora Saniel
Published 2015-05-01

High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines

by Edsel Maurice T. Salvana, Genesis May J. Samonte, Elizabeth Telan, Katerina Leyritana, Rosario Jessica Tactacan-Abrenica, Patrick R. Ching, Geraldine M. Arevalo, Niña Theresa Dungca, Christine Peñalosa-Ramos, Kevin Anthony R. Mendoza, Lyka F. Trinidad, Angelo dela Tonga, Jodor Lim, Raul Destura, Marissa Alejandria, Rontgene Solante, Lalaine Arcangel, Noel S. Palaypayon, Brian E. Schwem
Published 2020-06-01